Waiver Qualifying Training

Waiver Qualifying Training


Course Description

This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training.

Online Offerings

8-Hour Online Training for Physicians
Click here!
Note: Resident & Fellow ASAM Members (in training) receive complimentary access to the 8-hour online ASAM Treatment of Opioid Use Disorder Course.
Click here to become a member. Please note membership approval requires up to two business days.

24-Hour Online Training for PAs, NPs, CRNAs, CNMs, and CNSs
Begin 24-Hour Training Today
This training is divided into two parts of 8 hours and 16 hours. If you have already completed the 8-hour DATA2000 course, you will only need to complete the second part of the 16-hour course.

Please select a credit type below to begin the training. 

  • For AANP CE Credit: Click Here
  •  For AAPA Category 1 CME Credit or AMA PRA Category 1 CME Credit: Click Here 


Comprehensive Addiction and Recovery Act (CARA)
ASAM, AAPA and AANP have formed a collaborative to provide the 24-hour waiver training for physician assistants and nurse practitioners. The three organizations are authorized by statute to provide this training. Educational content has been identified and/or created to satisfy the 24-hour requirement as described in the Comprehensive Addiction and Recovery Act (CARA).

HR6 - SUPPORT for Patients and Communities Act
HR6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, added qualifying clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives to list of practitioners eligible to prescribe buprenorphine until October 1, 2023. The ASAM Treatment of Opioid Use Disorder Course is available for qualifying clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives.

To qualify for a waiver, NPs, CRNAs, CNMs, CNSs, and PAs must:
• Be licensed under state law to prescribe Schedule III, IV, or V medications for pain
• Complete not less than 24 hours of appropriate education through a qualified provider
• Through other training or experience, demonstrate the ability to treat and manage OUD
If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD

Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat Opioid Use Disorder before you apply for the waiver. Some states may have overriding state legislation that will prevent NPs/PAs from prescribing these medications even if Federal law allows it. Click here to learn more about applying for the waiver. 

Live Offerings

Blended - 4 hours online/4 hours live
The blended format combines 4 hours of self-paced online learning with 4 hours of live learning for a total of 8 hours.  The online portion is expected to be completed first as it covers the essential knowledge content.  The live portion will focus on the clinical application of the content covered online using case-based discussions. Upon registration, learners will be issued access to the online portion of the blended course through the ASAM e-Learning Center. 

8 Hours Live
All 8 hours are delivered in a live classroom setting. Check the Upcoming Courses page frequently for updated options. 

Who Should Attend

  • Physicians, Nurse Practitioners, and Physician Assistants who wish to obtain a waiver to prescribe buprenorphine in office based treatment of opioid use disorders
  • Clinicians and health care team members working with physicians who prescribe buprenorphine in office based treatment of opioid use disorders

Learning Objectives

  • Apply for a waiver to prescribe buprenorphine to their patients with opioid use disorders
  • Identify and assess patients who are appropriate for treatment with medications
  • Have specific knowledge concerning the use of medications to manage patients with addiction involving opioid use
  • Discuss the psychiatric and medical co-morbidities associated with opioid addiction

Questions? Contact ASAM’s Education Department

American Society of Addiction Medicine
11400 Rockville Pike, Suite 200, Rockville, MD 20852
Education Department
Phone: 301.656.3920 | Fax: 301.656.3815 | Email: education@ASAM.org